Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. It primarily focuses on the development of disease-modifying pipeline of exon-skipping, gene therapy, and gene editing product candidates targeting Duchenne disorder.